Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Innovation, institutions, integration, and infrastructure are the four key factors that will drive this sector ...

As global markets navigate a mixed economic landscape marked by declining consumer confidence and fluctuating indices, technology stocks continue to capture attention with their potential for high ...

Healthcare stocks have significantly lagged the broader market over the past year, leading some investors to question their ...

By hijacking these pathways, diseases can enhance their resilience, posing challenges for existing treatments. We aimed to uncover the exact mechanism by which zinc-dependent macrodomains regulate ADP ...

“Despite the recent introduction of new Alzheimer’s drugs, they will not work for everyone with dementia, so we want to study what can boost the brain’s resilience against pathological aging processes ...

Livewire rounded up 10 of Australia's brightest investment minds for their top growth stock picks for the year ahead.

Sullivan's visit comes as tension is brewing between India and China over Beijing's plan to build what it calls the "world's ...

To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health ...

In its Q3 2024 investor letter, Polaris Global Equity Strategy discussed the strong performance of the US biopharma sector, ...

In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about key trends impacting small-molecule APIs and ...

Blockchain technology is also poised for accelerated adoption, with advancements in Central Bank Digital Currencies (CBDCs) ...